Circulation. 2023 Nov 14;148(20):1606-1635. doi: 10.1161/CIR.0000000000001184. Epub 2023 Oct 9.
Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system and has profound impacts on morbidity and mortality. There are multisystem consequences of poor cardiovascular-kidney-metabolic health, with the most significant clinical impact being the high associated incidence of cardiovascular disease events and cardiovascular mortality. There is a high prevalence of poor cardiovascular-kidney-metabolic health in the population, with a disproportionate burden seen among those with adverse social determinants of health. However, there is also a growing number of therapeutic options that favorably affect metabolic risk factors, kidney function, or both that also have cardioprotective effects. To improve cardiovascular-kidney-metabolic health and related outcomes in the population, there is a critical need for (1) more clarity on the definition of cardiovascular-kidney-metabolic syndrome; (2) an approach to cardiovascular-kidney-metabolic staging that promotes prevention across the life course; (3) prediction algorithms that include the exposures and outcomes most relevant to cardiovascular-kidney-metabolic health; and (4) strategies for the prevention and management of cardiovascular disease in relation to cardiovascular-kidney-metabolic health that reflect harmonization across major subspecialty guidelines and emerging scientific evidence. It is also critical to incorporate considerations of social determinants of health into care models for cardiovascular-kidney-metabolic syndrome and to reduce care fragmentation by facilitating approaches for patient-centered interdisciplinary care. This presidential advisory provides guidance on the definition, staging, prediction paradigms, and holistic approaches to care for patients with cardiovascular-kidney-metabolic syndrome and details a multicomponent vision for effectively and equitably enhancing cardiovascular-kidney-metabolic health in the population.
心血管-肾脏-代谢健康反映了代谢危险因素、慢性肾脏病和心血管系统之间的相互作用,对发病率和死亡率有深远影响。心血管-肾脏-代谢健康不良有多种系统后果,最显著的临床影响是心血管疾病事件和心血管死亡率的高发生率。在人群中,心血管-肾脏-代谢健康不良的患病率很高,在那些健康的社会决定因素不利的人群中,这种情况更为严重。然而,也有越来越多的治疗选择对代谢危险因素、肾功能或两者都有有利影响,并且具有心脏保护作用。为了改善人群中的心血管-肾脏-代谢健康和相关结果,有必要(1)更清楚地定义心血管-肾脏-代谢综合征;(2)采用一种促进整个生命过程预防的心血管-肾脏-代谢分期方法;(3)预测算法包括与心血管-肾脏-代谢健康最相关的暴露和结果;(4)制定与心血管-肾脏-代谢健康相关的心血管疾病预防和管理策略,反映主要亚专科指南和新兴科学证据的协调。将健康的社会决定因素纳入心血管-肾脏-代谢综合征的护理模式,并通过促进以患者为中心的跨学科护理方法减少护理碎片化,这也是至关重要的。本总统顾问提供了关于心血管-肾脏-代谢综合征的定义、分期、预测模式以及患者护理的整体方法的指导,并详细说明了一个多方面的愿景,以有效地、公平地提高人群中的心血管-肾脏-代谢健康。